Læknaneminn - 01.04.1999, Blaðsíða 17

un er ekki hægt að „sanna“ eða koma með tilvitnanir
um. I okkar höndum er ekki munur á heildarmagaúr-
námi og hlutamagaúrnámi við þennan sjúkdóm þegar
horft er til dánatölu við aðgerðir. Mín ráðlegging er
því að gera heildarmagaúrnám við fjæræxlum.
Þrátt fyrir persónulegar skoðanir þá þarf ekki alltaf
að gera heildarmagaúrnám til lækningar og margar
heildarmagatökur í læknandi skyni á Vesturlöndum
eru ekki læknandi. Þrátt fyrir þetta þá er nauðsynlegt
í sívaxandi nræli til þess að ná gagngerri aðgerð (RO)
að framkvæma heildarmagaúrnám.
HEiMILDIR
1 Ársskýrsla Krabbameinsfélags íslands, 1999.
2 Bamias A, Pavlidis N. Systemic Chemotherapy in Gastric
Cancer: Where do we stand today? Oncologist 1998;3:171-
177.
3 Marelli D, Roviello F, De Stefano A, Fanetani M, Garosi L,
Messano A, Pinto E. Prognostic significance of CEA, CA 10-
9 and CA 72-4 preoperative serum levels in gastric carcinoma.
Oncology 1999;57:55-62.
4 Murakami R, Tsukuma H, Ubukata T, et al. Estimation of vali-
dity of mass screening program for gastric cancer in Osaka,
Japan. Cancer 1990;65:1255-1260.
5 Scheiman JM. Culler AF. Helicobacter pylori and gastric can-
cer.AmJ Mcd 1999;106:222-226.
6 Harris RA, Owens DK, Whitherell H, Parsonnet J. Helicobact-
er pylori and gastric cancer: what are the benefits of screening
only for CagA phenotype of H. pylori? Helicobacter
1999;4:69-76.
7 Rugge M. Bussatto G, Cassaro M, et al. Patients younger than
40 years with gastric carcinoma: Helicobacter pylori genotype
and associated gastritis phenotype. Cancer I999;85:2506-
2511.
8 Danesh J. Helicobacter pylori infection and gastric cancer: sy-
stemic review of epidemiological studies. Aliment Pharmacol
Ther 1999;13:851-856.
9 LaVecchia C, Negri E, Franceschi S, Gentile A. Family history
and the risk of stomach cancer and colorectal cancer. Cancer
1992;70:50-55.
10 Zanghieri G, et al. Familial Occurence of gastric cancer in the
2-year experience of a population-based registry. Cancer
1990;66:2047-2051.
11 Sugai T, Nakamura S, Uesugi N, Habano W, Yoshida T,
Tazawa H, Orii S, Suto T, Itoh C. Role of DNA aneuploidy,
overexpression of p53 gene product, and cellular proliferation
in the progression of gastric cancer. Cytometry 1999;38:111-
117.
12 Halling KC, Harper J, Moskaluk CA, Thibodeau SN, Petroni
GR, Ystein AS, Tosi P, Minacci C, Roviello F, Piva P,
Hamilton SR, Jackson CE, Powell SM. Origin of micriosta-
tellite instability in gastric cancer. Am J Pathol 1999; 155:205-
211.
Ottini L, Palli D, Falchetti M, et al. Microsatellite instability
in gastric cancer is associated with tumor location and family
history in high-risk population from Tuscany. Cancer Res
1997;57:4523-4529.
Semba S, Yokozaki H, Yasui W, Tahara E. Frequent microsa-
tellite instability and loss of heterozygosity in the region
including the BRCAl (17q21) in young patients with gastric
cancer. Int J Oncol 1998;6:1245-1251.
Guo RJ, Wang Y, Kaneko E, et al. Analyses of mutation and
loss of heterozygosity of coding sequences of the entire trans-
forming growth factor beta type II receptor gene in sporadic
human gastric cancer. Carcinogenesis 1998;9:1539-1544.
Guildford P, Hopkins J, Harraway J, et al. E-cadherin germline
mutation in familial gastric cancer. Nature 1998;392:402-405.
Iida S, Akiyama Y, Ichikawa W, Yamashita T. Nomizu T, Nihei
Z, Sugihara K, Yuasa Y. Infrequent germ-line mutation of the
E-cadherin gene in Japaneese familial gastric cancer kindreds.
Clin Cancer Res 1999;6:1445-1447.
Arnthorsson G, Tulinius H, Egilsson V, Sigvaldason H, Magn-
usson B. Thorarinsson H. Gastric cancer after gastrectomy. Inl
JCancer 1988;42:365-7.
Laurén P. The two histolgical main types of gastric carcinoma:
diffuse and so-called intestinal-type carcinoma. Acta Pathol
Microbiol Scand 1965;64:31-49.
Sobin LH and Wittekind Ch (eds)( 1977) UICC TNM
Classificationof Malignant Tumors 5th ed. John Wiley and
Sons, NY.
Jónasson L, Hallgrímsson J, Sigvaldason H, Olafsdóttir G,
Tulinius H. Gastric cancer in lceland: A retrospective study of
resectd specimens in a high-risk country during 30 years
(1960-1989). Int J Cancer 1994;57:793-98.
Noffsinger (ed) G1 Pathology Lippincott Raven 2ed. 1999.
Californian Cancer Registry, on the web.
Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric
cancer surgery in Japan and its limits of radicality. World J
Surg 1987;11:418-25.
Bonenkamp JJ, I Songun, Hermans J, Sasako M, Welvaart K,
Plukker JTM, et al. Randomised comparison of morbidity aft-
er D1 and D2 dissection for gastric cancer in 996 Dutch pati-
ents. Lancet 1995;345:745-48.
Gunnlaugsson S, Smith A, Guðbjartsson T, Oddsdóttir M,
Datye SS, Hallgrímsson J, Magnússon J. Magakrabbamein á
Islandi: Hvar stöndum við nú? Lifun 193 sjúklinga eftir maga-
brottnám á árunum 1980-1995. submitted
Siewer JR, BottcherK, Roder JD, Busch R, Hermanek P,
Meyer HJ. Prognostic relevance of systematic node dissection
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
LÆKNANEMINN • 1. tbl. 1999, 52. árg.
17